These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692 [TBL] [Abstract][Full Text] [Related]
4. Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Rao AK; Ziegler YS; McLeod IX; Yates JR; Nardulli AM Mol Endocrinol; 2008 May; 22(5):1113-24. PubMed ID: 18258688 [TBL] [Abstract][Full Text] [Related]
5. Altered target gene regulation controlled by estrogen receptor-alpha concentration. Fowler AM; Solodin NM; Valley CC; Alarid ET Mol Endocrinol; 2006 Feb; 20(2):291-301. PubMed ID: 16179380 [TBL] [Abstract][Full Text] [Related]
6. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Lin Z; Reierstad S; Huang CC; Bulun SE Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins. Higgins KJ; Liu S; Abdelrahim M; Yoon K; Vanderlaag K; Porter W; Metz RP; Safe S Endocrinology; 2006 Jul; 147(7):3285-95. PubMed ID: 16574784 [TBL] [Abstract][Full Text] [Related]
9. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells. Laganière J; Deblois G; Giguère V Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516 [TBL] [Abstract][Full Text] [Related]
10. The AF-1 activation function of estrogen receptor α is necessary and sufficient for uterine epithelial cell proliferation in vivo. Abot A; Fontaine C; Raymond-Letron I; Flouriot G; Adlanmerini M; Buscato M; Otto C; Bergès H; Laurell H; Gourdy P; Lenfant F; Arnal JF Endocrinology; 2013 Jun; 154(6):2222-33. PubMed ID: 23580568 [TBL] [Abstract][Full Text] [Related]
11. Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus. Hewitt SC; Collins J; Grissom S; Hamilton K; Korach KS Endocrinology; 2006 May; 147(5):2203-14. PubMed ID: 16469803 [TBL] [Abstract][Full Text] [Related]
13. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex. Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412 [TBL] [Abstract][Full Text] [Related]
14. Novel DNA motif binding activity observed in vivo with an estrogen receptor α mutant mouse. Hewitt SC; Li L; Grimm SA; Winuthayanon W; Hamilton KJ; Pockette B; Rubel CA; Pedersen LC; Fargo D; Lanz RB; DeMayo FJ; Schütz G; Korach KS Mol Endocrinol; 2014 Jun; 28(6):899-911. PubMed ID: 24713037 [TBL] [Abstract][Full Text] [Related]
15. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue. Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332 [TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene. Daverey A; Saxena R; Tewari S; Goel SK; Dwivedi A J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):93-101. PubMed ID: 19460436 [TBL] [Abstract][Full Text] [Related]
19. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727 [TBL] [Abstract][Full Text] [Related]
20. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation. Al-Dhaheri MH; Rowan BG Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]